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Abstract 
AIM: This study was to determine the sensitivity of Klebsiella pneumonia isolated from pus specimens of post-
surgery patients in Medan, Indonesia to selected antibiotics. 
METHODS: Samples were collected at the Laboratory of Microbiology, Faculty of Medicine, Universitas Sumatera 
Utara, Medan, Indonesia. The isolated bacteria were identified by Gram’s stain, colony characteristics, and 
biochemical tests. Susceptibility of K. pneumoniae isolates were tested to selected antibiotics including amikacin, 
meropenem, levofloxacin, ciprofloxacin, co-trimoxazole, ceftazidime, cefoperazone, cefuroxime, cefepime, 
cefotaxime, tetracycline, chloramphenicol, amoxicillin and ampicillin with Kirby Bauer method by measuring the 
inhibitory zone. 
RESULTS: A total of 20 K. pneumoniae isolates were obtained in this study. The results showed that K. 
Pneumonia isolates exhibited good sensitivity to amikacin (100%) and meropenem (80%). Sensitivity of 
levofloxacin (60%), ceftazidime (55%), ciprofloxacin (55%), cefoperazone (50%), and co-trimoxazole (50%) were 
moderate for the bacterial isolates. K. Pneumoniae isolates indicated low sensitivity to cefuroxime (45%), 
chloramphenicol (35%), cefepime (30%), cefotaxime (30%), tetracycline (30%), amoxicillin (5%), and ampicillin 
(5%). 
CONCLUSION: This study concludes that K. pneumoniae isolates are most sensitive to amikacin and less 
sensitive to ampicillin and amoxicillin. 
 
 
 
 
 
 
 
Introduction 
 
Klebsiella pneumoniae belongs to the family 
of Enterobacteriaceae, it is a Gram-negative bacteria, 
non-motile, and aerobic rod-shaped bacteria. Their 
mucoid colonies grow on agar media and are capable 
of fermenting lactose [1]. K. pneumoniae commonly 
presents in sewage, surface water, soil, and plants, as 
well as on mucosal surface of mammals. In human, 
this bacteria is found as saprophyte in 
nasopharyngeal and intestinal tracts. The bacteria 
cause hospital-aquired infections including respiratory 
tract infections, urinary tract infections, and 
bloodstream infections [2]. In addition, K. pneumoniae 
is also identified on wound after skin surgery [3]. 
World Health Organization reported 
resistance of K. pneumoniae to third-generation 
cephalosporins and carbapenems in the world [4]. 
This situation causes treatment of infectious diseases 
become difficult and produce more serious problem 
for the human life [5]. The emergence of resistant K. 
pneumoniae strain to antibiotics in some Asian 
countries has also been reported [6], [7], [8], [9], [10]. 
However, there are limited informations regarding the 
susceptibility of the bacteria to antibiotics in Indonesia 
regions. Hence this study was performed to 
investigate the susceptibilty of K. Pneumonia isolated 
from pus specimens of post-surgery patients in 
Medan, Indonesia. 
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Material and Methods 
 
Chemicals 
Bacterial growth media including brain heart 
infusion agar, Mac Conkey agar, eosin methyl blue 
agar, sugarsbroth, triple sugar iron agar, urea broth, 
methyl red media, Voges-Proskauermedia, and 
Mueller Hinton agar (MHA) were obtained from Oxoid 
(Hampshire, UK). Paper discs containing standard 
antibiotics namely ampicillin 10 µg, amoxycillin 25 µg, 
chloramphenicol 30 µg, cefuroxyme 30 µg, cefotaxime 
30 µg, cefoperazone 75 µg, cefepime 30 µg, 
meropenem 10 µg, amikacin 30 µg, tetracycline 30 
µg, ciprofloxacin 5 µg, levofloxacin 5 µg, co-
trimoxazole 25 µg, and ceftazidime 30 µg were 
purchased from Oxoid (Hampshire, UK). Reagents 
(chrystal violet, 96% ethanol, iodin, safranin O, 
ammonium oxalate, oksalat, para-
dimethylaminobenzaldehyde, butanol, acid chloride, 
-naphtol 5%, KOH 40%, and distilled water) were 
supplied by Microbiology Laboratory, Faculty of 
Medicine, Universitas Sumatera Utara (Medan, 
Indonesia). 
 
Sample collection 
Pus specimens of post-surgery patients in 
Medan, Indonesia were collected in the Microbiology 
Laboratory, Faculty of Medicine, Universitas Sumatera 
Utara from August 2, to September 7, 2016.  
 
Antibiotic susceptibility testing of bacterial 
 isolates 
The specimens were aseptically transferred 
into brain heart infussion, cultured on eosin metil blue 
agar plates, and then incubated overnight at 37°C. 
After 24 hours, isolated colony was identified by 
observing their characteristics through Gram’s 
staining, viable colonies, motility test, and biochemical 
tests such as indole, methyl red, Voges-Proskauer, 
Simon’s citrate, urease, and sugars fermentation [11]. 
A Kirby-Bauer disc diffusion method from the Clinical 
and Laboratory Standard Institute (2016) was adopted 
to investigate the antibiotic susceptibility of K. 
pneumoniae isolates [12]. 
 
 
Results 
 
Bacterial isolates characteristics 
The results indicated that the bacterial 
colonies were mucoid, large dome shaped and pink in 
colour on eosine methylene blue agar media (Figure 
1A). The bacterial isolates were rod-shaped and pink 
colour with Gram staining which indicated Gram-
negative bacteria (Figure 1B). Biochemical testing of 
the bacterial isolates produced positive results with 
Voges-Proskauer, Simmons' citrate, and sugar 
fermentation tests, but negative reactions were 
identified by Indol, methyl red, and motility tests. The 
similar results have also been reported by Patel et al., 
(2017) and Abdullah and Zghair (2016) [13], [14]. 
Accordingly, these bacterial isolates characteristics 
were spesific for K. pneumoniae. A total of 20 K. 
pneumoniae isolates were obtained in this study. 
 
Figure 1: Characteristics of Klebsiella pneumoniae on eosin 
methylen blue agar media (A) and Gram staining (B) 
 
Sensitivity patterns of K. pneumoniae to 
 selected antibiotics 
In the present study, susceptibility testing of 
K. pneumoniaeisolates from pus specimens of post-
surgery patients to several antibiotics was determined 
by measuring the bacterial growth inhibition zone 
around the antibiotic discs. The bacterial susceptibility 
to antibiotics is classified into three criteria, namely 
sensitive, intermediate, and resistant [12]. The results 
demonstrated that K. Pneumoniae isolates produced 
different sensitivity to antibiotics class (Table 1).  
Table 1: Sensitivity patterns of K. pneumoniae isolated from 
pus specimens of post-surgery patients to selected antibiotics 
Antibiotic Class Antibiotic’sName 
Isolate Number (%) 
S I R 
Aminoglycoside Amikacin 20 (100.0%) 0 (0.0%) 0 (0.0%) 
Carbapenem Meropenem 16 (80.0%) 1 (5.0%) 3 (15.0%) 
Fluoroquinolone 
Levofloxacin 12 (60.0%) 1 (5.0%) 7 (35.0%) 
Ciprofloxacin 11 (55.0%) 1 (5.0%) 8 (40.0%) 
Drug Combination Co-trimoxazole 10 (50.0%) 0 (0.0%) 10 (50.0%) 
Cephalosporin 
Ceftazidime 11 (55.0%) 2 (10.0%) 7 (35.0%) 
Cefoperazone 10 (50.0%) 5 (25.0%) 5 (25.0%) 
Cefuroxyme 9 (45.0%) 2 (10.0%) 9 (45.0%) 
Cefepime 7 (35.0%) 7 (35.0%) 6 (30.0%) 
Cefotaxime 6 (30.0%) 1 (5.0%) 13 (65.0%) 
Chloramphenicol Chloramphenicol 7 (35.0%) 0 (0.0%) 13 (65.0%) 
Tetracycline Tetracycline 6 (30.0%) 2 (10.0%) 12 (60.0%) 
Penicillin 
Ampicillin 1 (5.0%) 0 (0.0%) 19 (95.0%) 
Amoxicillin 1 (5.0%) 0 (0.0%) 19 (95.0%) 
 
 
Discussion 
 
Although some bacterial isolates exhibited 
good sensivity, but the emergence of bacterial 
resistance to antibiotics tested also detected. 
A B
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Ampicillin and amoxicillin which are classified into 
penicilline derivates were relatively inactive to K. 
pneumoniaewith the number of resistant isolates of 
more than 90%. According to Ravichitra et al., (2014), 
K. pneumoniae isolated from pus, sputum, and urine 
samples also resistant to some antibiotics, especially 
amoxyclav and ofloxacin [15]. Penicillin resistance is 
due to the ability of K. pneumoniae to carry plasmids 
producing beta-lactamse variants [16]. As we know 
that beta-lactamase production is the most common 
mechanism among Gram negative bacteria [17]. 
This study also indicated that chloramphenicol 
and tetracycline have low sensitivity to K. pneumoniae 
isolates. The similar result has been reported by other 
researchers [18], [19]. Chloramphenicol resistance is 
commonly caused by enzymes activity which add 
acetyl groups to antibiotics. Acetylated 
chloramphenicol cannot be bound to the 50S subunit 
of the bacterial ribosome, so it is unable to inhibit 
protein synthesis. In addition, the bacteria resistant 
carries a plasmid with a gene that codes for 
chloramphenicol acetyltransferase. This enzyme 
inactivates chloramphenicol pass through the plasma 
membrane and enters the cell [20]. The low sensitivity 
of tetracycline in K. Pneumonia due to the mutations 
in the chromosomes in the outer membrane of 
bacteria that, it leads to the decreasing of 
tetracyclines penetration into the cell [21]. 
Moderate sensitivity of co-trimoxazole, 
cephalosporin, and fluoroquinolone in K. pneumonia 
isolates has been detected in our study. This finding 
also supported by other researchers [22], [23], [24]. 
Co-trimoxazole, a combination of trimethoprim and 
sulfamethoxazole, blocks the folate synthesis pathway 
in bacteria. Sulfamethoxazole inhibits the enzyme 
responsible for the incorporation of para-
aminobenzoic acid (PABA) into a precursor of folic 
acid, therefore blocking folic acid production in 
bacteria. Trimetoprim is a potent inhibitor of the 
enzyme dihydrofolatereductase and interferes with the 
conversion of folic acid to folinic acid. Folinic acid is 
required in the production of purine as the backbone 
of the bacterial DNA. Co-trimoxazole resistance is due 
to the bacterial capability to produce an enzyme as 
alternative target which resistant to antibiotic inhibition 
[25]. K. pneumoniae can also develop biofilm-forming 
mechanism to survive under prolonged exposure of 
antibiotics such as ciprofloxacin [26], gentamicin, and 
cefotaxime [27]. The change of the target and 
decrease the accumulation of fluoroquinolones 
caused by the impermeability of the membrane and 
excessive expression of the efflux pump mechanisms 
of this bacteria resistant to fluoroquinolones [28]. 
Fluoroquinolone class of antibiotic resistance caused 
by mutations in the gene encoding the DNA gyrase 
enzyme produced active cause but cannot be bound 
by fluoroquinolone [29]. 
In addition, resistance of K. pneumoniae 
isolated from pus specimens to carbapenem class 
were also detected in this study. Carbapenems are 
highly stable to beta-lactamase hydrolysis, so it is a 
drug of choice for treatment of serious infections 
caused by K. pneumonia producing extended 
spectrum beta-lactamase [30]. However, the bacterial 
resistance to carbapenem is possible since K. 
pneumonia capable to produce an enzyme which 
called carbapenemase [31]. 
Interestingly, all of K. pneumoniae isolates 
were sensitive to amikacin. A study by Simanjuntak 
(2014) also found that the bacteria isolated from urine 
of patients with infected urinary tract [19]. Amikacin is 
an aminoglycoside antibiotic that inhibits protein 
synthesis in bacteria. This antibiotic binds to the 30S 
ribosomal subunit mRNA cause reading errors, so 
bacteria cannot synthesize proteins for growth. 
Amikacin is also highly resistant to modification by the 
bacterial enzymesleading many bacteria are sensitive 
to this antibiotic [32]. 
In conclusion, K. penumoniae isolated from 
pus specimens of post-surgery patients in Medan, 
Indonesia has been resistant to ampicillin, amoxicillin, 
cefepim, cefotaxime, cefuroxyme, cefoperazone, 
ceptazidime, tetreacycline, chloramphenicol, co-
trimoxazole, ciprofloxacin, levofloxacin, and 
meropenem. However, the bacterial has shown good 
sensitivity to amikacin. 
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